D. Adamczyk

Equibles does not estimate personal net worth.

About D. Adamczyk

Earlier roles on record: Board Member at Johnson & Johnson (JNJ) until May 31, 2025. Johnson & Johnson reported in an 8-K filed April 30, 2025 that D. Adamczyk retired as Board of Directors, effective May 31, 2025.

“D. Adamczyk notified the Company that he intends to retire from the Company’s Board of Directors in connection with an announcement on April 23rd that he will join Goldman Sachs as a Partner.”

Johnson & Johnson Form 8-K, filed April 30, 2025 · Read the filing

Affiliation history

Johnson & Johnson (JNJ)
Board Member

Proxy statement

2022-01-01–2025-05-31

Company network

Johnson & Johnson

JNJ

Drug Manufacturers - General · Healthcare

Board Member

2022-01-01–2025-05-31

Recent activity

Executive change Retired: Board of Directors Johnson & Johnson (JNJ)
2025-05-31